Publications of M. Uhr
All genres
Journal Article (287)
121.
Journal Article
162 (6), pp. 1059 - 1065 (2010)
Ghrelin affects the hypothalamus-pituitary-thyroid axis in humans by increasing free thyroxine and decreasing TSH in plasma. European Journal of Endocrinology 122.
Journal Article
35 (7), pp. 1583 - 1592 (2010)
Gender-Specific Association of Galanin Polymorphisms with HPA-Axis Dysregulation, Symptom Severity, and Antidepressant Treatment Response. Neuropsychopharmacology 123.
Journal Article
67 (9 Suppl.1), p. 129S - 129S (2010)
Genome-Wide Gene-Expression Profiles Following Glucocorticoid Stimulation Associated with Major Depression. Biological Psychiatry 124.
Journal Article
67 (4), pp. 348 - 359 (2010)
Association of Genetic Variants in the Neurotrophic Receptor-Encoding Gene NTRK2 and a Lifetime History of Suicide Attempts in Depressed Patients. Archives of General Psychiatry 125.
Journal Article
30 (2), pp. 209 - 211 (2010)
Single Nucleotide Polymorphism in the Drug Transporter Gene ABCB1 in Treatment-Resistant Depression Clinical Practice. Journal of Clinical Psychopharmacology 126.
Journal Article
35 (2), pp. 297 - 304 (2010)
Ghrelin increases slow wave sleep and stage 2 sleep and decreases stage 1 sleep and REM sleep in elderly men but does not affect sleep in elderly women. Psychoneuroendocrinology 127.
Journal Article
35 (3), pp. 792 - 805 (2010)
Valproate and Amitriptyline Exert Common and Divergent Influences on Global and Gene Promoter-Specific Chromatin Modifications in Rat Primary Astrocytes. Neuropsychopharmacology 128.
Journal Article
61 (3), pp. 113 - 121 (2010)
Sleep and active renin levels - interaction with age, gender growth hormone and cortisol. Neuropsychobiology 129.
Journal Article
81 (8), pp. 973 - 979 (2010)
Liquordiagnostik bei CT-negativer Subarachnoidalblutung. Nervenarzt 130.
Journal Article
117 (10), p. 660 - 660 (2009)
Predictors of neuropsychiatric side effects and therapy response of dopamine agonist therapy in patients with prolactinomas: a clinical study concept. Experimental and Clinical Endocrinology & Diabetes 131.
Journal Article
73, pp. 665 - 666 (2009)
Pharmacogenetics of antidepressant treatment outcome - Results from a genome-wide multilocus analysis including clinical predictors. Annals of Human Genetics 132.
Journal Article
42 (5), p. 222 - 222 (2009)
Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - Findings from the Munich Antidepressant Response Signature project. Pharmacopsychiatry 133.
Journal Article
66 (9), pp. 966 - 975 (2009)
A Genomewide Association Study Points to Multiple Loci That Predict Antidepressant Drug Treatment Outcome in Depression. Archives of General Psychiatry 134.
Journal Article
42 (5), p. 224 - 224 (2009)
A genome-wide association study points to multiple loci predicting antidepressant treatment outcome in depression. Pharmacopsychiatry 135.
Journal Article
42 (5), p. 226 - 226 (2009)
Polymorphisms in tryptophan hydroxylase 2 leading to decreased serotonergic activity contribute to elevated risk for metabolic syndrome in depression. Pharmacopsychiatry 136.
Journal Article
42 (5), pp. 226 - 227 (2009)
Ghrelin plasma levels are not altered in major depression. Pharmacopsychiatry 137.
Journal Article
42 (5), p. 228 - 228 (2009)
The influence of psychosocial factors on the neurobiological stress mechanism in patients with remitted depression. Pharmacopsychiatry 138.
Journal Article
42 (5), p. 228 - 228 (2009)
The influence of a stress challenge test on the cognitive performance in a Go/No-Go paradigm and its correlation with HPA system dysregulation in healthy subjects and patients with remitted depression. Pharmacopsychiatry 139.
Journal Article
42 (5), p. 230 - 230 (2009)
The neuronal transporter gene SLC6A15 confers risk to major depression. Pharmacopsychiatry 140.
Journal Article
42 (5), p. 238 - 238 (2009)
Polymorphisms in the drug transporter gene ABCB1 in treatment resistant depression: clinical practice. Pharmacopsychiatry